Main Management’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$85K Hold
1,030
0.01% 73
2025
Q1
$84K Sell
1,030
-45,200
-98% -$3.69M 0.01% 75
2024
Q4
$4.16M Sell
46,230
-20,330
-31% -$1.83M 0.34% 30
2024
Q3
$6.58M Sell
66,560
-189,620
-74% -$18.7M 0.54% 29
2024
Q2
$23.8M Buy
256,180
+32,100
+14% +$2.98M 1.96% 14
2024
Q1
$21.3M Buy
224,080
+1,500
+0.7% +$142K 1.82% 19
2023
Q4
$19.9M Buy
222,580
+2,575
+1% +$230K 1.95% 18
2023
Q3
$16.1M Buy
220,005
+6,686
+3% +$488K 1.63% 20
2023
Q2
$17.7M Sell
213,319
-261,501
-55% -$21.8M 1.8% 18
2023
Q1
$36.2M Buy
474,820
+952
+0.2% +$72.6K 3.84% 9
2022
Q4
$39.3M Buy
473,868
+105,733
+29% +$8.78M 4.54% 7
2022
Q3
$29.2M Buy
368,135
+5,884
+2% +$467K 3.61% 8
2022
Q2
$26.9M Buy
362,251
+86,869
+32% +$6.45M 3.21% 8
2022
Q1
$24.8M Buy
275,382
+213,301
+344% +$19.2M 2.55% 12
2021
Q4
$6.95M Sell
62,081
-2,216
-3% -$248K 0.7% 33
2021
Q3
$8.08M Buy
64,297
+1,289
+2% +$162K 0.87% 30
2021
Q2
$8.53M Sell
63,008
-745
-1% -$101K 0.92% 27
2021
Q1
$8.65M Sell
63,753
-45,095
-41% -$6.12M 0.96% 31
2020
Q4
$15.3M Sell
108,848
-5,620
-5% -$791K 1.96% 19
2020
Q3
$12.8M Buy
114,468
+9,655
+9% +$1.08M 1.79% 18
2020
Q2
$11.7M Buy
104,813
+5,742
+6% +$643K 1.86% 19
2020
Q1
$7.67M Sell
99,071
-8,680
-8% -$672K 1.42% 23
2019
Q4
$10.2M Buy
107,751
+4,223
+4% +$402K 1.38% 21
2019
Q3
$7.89M Sell
103,528
-54,390
-34% -$4.15M 1.1% 22
2019
Q2
$13.9M Buy
157,918
+845
+0.5% +$74.1K 2.01% 16
2019
Q1
$14.2M Buy
157,073
+2,029
+1% +$184K 2.09% 17
2018
Q4
$11.1M Buy
155,044
+2,261
+1% +$162K 1.7% 18
2018
Q3
$14.6M Sell
152,783
-9,069
-6% -$869K 2.11% 18
2018
Q2
$15.4M Buy
161,852
+1,476
+0.9% +$141K 2.07% 17
2018
Q1
$14.1M Buy
160,376
+9,658
+6% +$847K 1.93% 17
2017
Q4
$12.8M Buy
150,718
+4,618
+3% +$392K 1.86% 18
2017
Q3
$12.6M Sell
146,100
-260
-0.2% -$22.5K 1.88% 17
2017
Q2
$11.3M Buy
146,360
+978
+0.7% +$75.5K 1.73% 17
2017
Q1
$10.1M Buy
+145,382
New +$10.1M 1.62% 16